Funder: National Institutes of Health
Due Dates: November 5, 2026 (Renewal/Resubmission/Revision) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/Resubmission/Revision) | January 7, 2028 (Closing date)
Funding Amounts: No budget limit; requests must reflect project needs; maximum project period of 5 years; no cost sharing required
Summary: Supports basic, mechanistic research into biological and genetic contributors to cancer health disparities.
Key Information: Clinical trials are not allowed; age- or sex-disparity studies without race/ethnicity variables are nonresponsive.
Description
The National Cancer Institute (NCI), part of the National Institutes of Health, supports R01 research projects investigating biological and genetic contributors to cancer health disparities. Supported work includes mechanistic studies in cancer biology and prevention, development and testing of methodologies and models, and secondary data analyses. Projects must investigate how race/ethnicity and/or other social determinants interact with cancer biology to explain unequal cancer burdens.
The program aims to strengthen a nationwide cohort of scientists with basic research expertise in cancer health disparities and expand resources such as biospecimens, patient-derived models, and research methods. Topics span early detection and prevention, cancer initiation and progression, symptom management during cancer and treatment, and technology development. Immediate clinical translation is not required.
